(Q45885509)

17 December 2017

title

Desmopressin therapy in patients with acquired factor VIII inhibitors (English)

1 reference

17 December 2017

1 reference

S M Naorose-Abidi

1

1 reference

17 December 2017

L R Bond

series ordinal

2

1 reference

17 December 2017

A Chitolie

series ordinal

3

1 reference

17 December 2017

D H Bevan

series ordinal

4

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

17 December 2017

published in

The Lancet

1 reference

17 December 2017

volume

1

1 reference

17 December 2017

issue

8581

1 reference

17 December 2017

page(s)

366

1 reference

17 December 2017

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991169-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991169-5

inferred from DOI database lookup

7 January 2021

based on heuristic

The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991169-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(88)91169-5

1 reference

17 December 2017

1 reference

17 December 2017